NanoViricides Won the IAIR AWARD as Best North American Company for Leadership in the Nanomedicine Sector
Business Wire - Wed Apr 16, 7:43AM CDT
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
NanoViricides, Inc. President Dr. Anil R. Diwan Recognized as "Researcher of the Year" by BusinessNewHaven, a Connecticut Area Business Journal
Business Wire - Mon Mar 31, 7:55AM CDT
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
SeeThruEquity Initiates Research Coverage on NanoViricides, Inc.
Business Wire - Thu Mar 27, 8:01AM CDT
SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on NanoViricides, Inc. (NYSE-MKT:NNVC), a development stage company that is creating special purpose nanomaterials for viral therapy.
NanoViricides awarded fundamental PCT patents in Australia and the Philippines for antiviral applications and diseases
M2 - Tue Mar 25, 6:00AM CDT
Nanomaterials company NanoViricides (NYSE MKT:NNVC) reported on Monday the receipt of fundamental PCT patents in Australia and the Philippines based on its nanoviricides technology.
NanoViricides, Inc. Announces Issuance of Fundamental Patents in Australia and the Philippines
Business Wire - Mon Mar 24, 6:00AM CDT
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
NanoViricides, Inc. Has Posted Dr. Seymour's CEO Letter on the Company Website - Dr. Seymour to Present Today at the Roth Capital Conference
Business Wire - Wed Mar 12, 6:01AM CDT
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
NanoViricides Inc. Denies Rumor That It Is Being Acquired For $4.5B
Business Wire - Fri Mar 07, 6:00AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
NanoViricides, Inc. Announces It Has Commenced Action Against Seeking Alpha to Obtain Identity of the Anonymous Short Seller
Business Wire - Wed Mar 05, 6:01AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of NANOVIRICIDES, INC. for Possible Violations of Federal Securities Laws
Business Wire - Mon Mar 03, 11:45AM CST
Levi & Korsinsky is investigating NanoViricides, Inc. ("NanoViricides" or the "Company"
Triphase Receives FDA Orphan Drug Designation for Marizomib in Multiple Myeloma
Business Wire - Thu Feb 27, 7:01AM CST
Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA)'s Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.
NanoViricides, Inc. Reports its President & Chairman Dr. Diwan Purchased its Common Stock in the Open Market
Business Wire - Wed Feb 26, 6:00AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
INVESTOR ALERT: Investigation of NanoViricides, Inc. Announced by Glancy Binkow & Goldberg LLP
Business Wire - Tue Feb 25, 5:32PM CST
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of NanoViricides, Inc. ("NanoViricides" or the "Company"
NanoViricides Reports that it is Evaluating Purchase of the New Facility and cGMP Pilot Production Plant instead of a Lease
Business Wire - Thu Feb 20, 6:00AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Two Drug Candidates
Business Wire - Tue Feb 18, 6:00AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Feb 16, 9:30AM CST
There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers. Company Feb. 14 Weekly Loss Infoblox $19.41 42% ...
NanoViricides, Inc. Demands Retraction of the Baseless and Inaccurate Libelous Article by an Anonymous Short Seller Posted on SeekingAlpha Website
Business Wire - Fri Feb 14, 9:06AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company"
Harwood Feffer LLP Announces Investigation of NanoViricides, Inc.
PR Newswire - Wed Feb 12, 7:30PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against NanoViricides, Inc. ("NNVC" or the "Company"
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of NanoViricides, Inc.
Business Wire - Wed Feb 12, 4:32PM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of NanoViricides, Inc. ("NanoViricides" or the "Company"